Ondansetron use is associated with lower COVID-19 mortality in a Real-World Data network-based analysis
Gregory M. Miller, J. Austin Ellis, Rangaprasad Sarangarajan, Amay Parikh, Leonardo O. Rodrigues, Can Bruce, Nischal Mahaveer Chand, Steven R. Smith, Kris Richardson, Raymond Vazquez, Michael A. Kiebish, Chandran Haneesh, Elder Granger, Judy Holtz, View ORCID ProfileJacob Hinkle, Niven R. Narain, Bret Goodpaster, Jeremy C. Smith, Daniel S. Lupu
doi: https://doi.org/10.1101/2021.10.05.21264578
Gregory M. Miller
1BERG, Framingham, MA 01701
J. Austin Ellis
4National Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA
Rangaprasad Sarangarajan
1BERG, Framingham, MA 01701
Amay Parikh
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Leonardo O. Rodrigues
1BERG, Framingham, MA 01701
Can Bruce
1BERG, Framingham, MA 01701
Nischal Mahaveer Chand
1BERG, Framingham, MA 01701
Steven R. Smith
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Kris Richardson
1BERG, Framingham, MA 01701
Raymond Vazquez
3AdventHealth Information Technology, Orlando, FL 32804
Michael A. Kiebish
1BERG, Framingham, MA 01701
Chandran Haneesh
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Elder Granger
1BERG, Framingham, MA 01701
Judy Holtz
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Jacob Hinkle
5Computational Sciences and Engineering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA
Niven R. Narain
1BERG, Framingham, MA 01701
Bret Goodpaster
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Jeremy C. Smith
6Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, USA
7UT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA
Daniel S. Lupu
2Translational Research Institute, AdventHealth Research Institute, Orlando, FL 32804, USA
Posted October 12, 2021.
Ondansetron use is associated with lower COVID-19 mortality in a Real-World Data network-based analysis
Gregory M. Miller, J. Austin Ellis, Rangaprasad Sarangarajan, Amay Parikh, Leonardo O. Rodrigues, Can Bruce, Nischal Mahaveer Chand, Steven R. Smith, Kris Richardson, Raymond Vazquez, Michael A. Kiebish, Chandran Haneesh, Elder Granger, Judy Holtz, Jacob Hinkle, Niven R. Narain, Bret Goodpaster, Jeremy C. Smith, Daniel S. Lupu
medRxiv 2021.10.05.21264578; doi: https://doi.org/10.1101/2021.10.05.21264578
Ondansetron use is associated with lower COVID-19 mortality in a Real-World Data network-based analysis
Gregory M. Miller, J. Austin Ellis, Rangaprasad Sarangarajan, Amay Parikh, Leonardo O. Rodrigues, Can Bruce, Nischal Mahaveer Chand, Steven R. Smith, Kris Richardson, Raymond Vazquez, Michael A. Kiebish, Chandran Haneesh, Elder Granger, Judy Holtz, Jacob Hinkle, Niven R. Narain, Bret Goodpaster, Jeremy C. Smith, Daniel S. Lupu
medRxiv 2021.10.05.21264578; doi: https://doi.org/10.1101/2021.10.05.21264578
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (696)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12508)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4375)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (890)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2179)
- Ophthalmology (620)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6726)
- Radiology and Imaging (1478)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)